
In this episode of Clinical Lab Chat, CLP’s director of business intelligence, Chris Wolski, discusses how point-of-care testing improves access to both diagnostics and treatment with Seth Egan, co-founder of and chief commercialization officer for Co-Diagnostics. Among the topics they cover in their wide-ranging conversation:How and why point-of-care testing improves both diagnostic and treatment access.The key equation of simplicity, cost, and turnaround time (TAT) as the means of providing point-of-care testing.The rationale behind the menu of tests Co-Diagnostics is developing.The role of clinical labs in point-of-care testing continuum.The future of point-of-care testing. Further listening: How You Can Harness AI in Your Laboratory
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Advancements in HLA Matching and Antibody Detection

What Do the New ASCCP Guidelines Mean for Clinical Labs?

Alpha-Synuclein: Adding Precision to Neurodegenerative Testing

C Diff: How Awareness Improves Diagnostics and Treatments
Free AI-powered recaps of Clinical Lab Chat and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.